Download PDF

1. Company Snapshot

1.a. Company Description

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland.The company sells medical equipment used in diagnostics and therapy, and nuclear medicine; the development of IT solutions used in radiology; and produces and sells radiopharmaceutical products used in diagnostics for oncology.It also operates a research laboratory for diagnostic imaging systems and a service center for medical equipment.


In addition, the company offers maintenance services for medical equipment, as well as acceptance and specialist tests.Synektik Spólka Akcyjna was founded in 2001 and is based in Warsaw, Poland.

Show Full description

1.b. Last Insights on SNT

Synektik Spólka Akcyjna's recent performance has been positively driven by its position as a high-growth tech stock in Europe. The European market's rally in technology stocks and expectations for lower U.S. borrowing costs have created a favorable environment. As a company likely leveraging innovation and adaptability to thrive despite economic uncertainties, Synektik Spólka Akcyjna may capitalize on expanding business activity. Its potential for growth is notable, with European markets reaching record levels and investors seeking undervalued stocks.

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

3. NewsRoom

Card image cap

High Growth Tech Stocks in Europe for November 2025

Nov -20

Card image cap

European Stocks That May Be Undervalued In November 2025

Nov -07

Card image cap

Undiscovered Gems in Europe for November 2025

Nov -06

Card image cap

High Growth Tech Stocks in Europe to Watch October 2025

Oct -22

Card image cap

3 European Stocks Estimated To Be Up To 35.5% Below Intrinsic Value

Oct -09

Card image cap

High Growth Tech Stocks In Europe For September 2025

Sep -23

Card image cap

Three European Undiscovered Gems With Promising Potential

Sep -18

Card image cap

European Equities Estimated Below Fair Value In September 2025

Sep -03

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (3.58%)

6. Segments

Equipment Diagnostic and Information Technology

Expected Growth: 3.5%

Synektik Spólka Akcyjna's Equipment Diagnostic and Information Technology segment growth of 3.5% is driven by increasing demand for predictive maintenance, adoption of Industry 4.0 technologies, and rising need for efficient equipment monitoring. Additionally, growing investments in digitalization and automation across industries, such as manufacturing and energy, are also contributing to this growth.

Production of Radiopharmaceuticals

Expected Growth: 4.5%

Synektik Spólka Akcyjna's 4.5% growth in radiopharmaceutical production is driven by increasing demand for cancer treatments, advancements in nuclear medicine, and strategic partnerships with hospitals and research institutions. Additionally, investments in R&D, expansion of production capacity, and favorable regulatory environments contribute to the company's growth momentum.

7. Detailed Products

Synektik IoT Platform

A comprehensive IoT platform that enables the connection and management of various devices, sensors, and systems, providing real-time data and insights for informed decision-making.

Smart Factory Solutions

A suite of solutions that leverage IoT, AI, and machine learning to optimize manufacturing processes, improve efficiency, and reduce costs.

Cybersecurity Services

A range of cybersecurity services, including penetration testing, vulnerability assessment, and incident response, to protect against cyber threats.

Data Analytics and AI

Advanced data analytics and AI solutions that provide insights, predictions, and recommendations to drive business growth and improvement.

Industrial Automation Solutions

A range of industrial automation solutions, including SCADA systems, PLC programming, and HMI development, to optimize industrial processes.

IT Consulting and Integration

Expert IT consulting and integration services to design, implement, and integrate IT systems, ensuring seamless operations and efficiency.

8. Synektik Spólka Akcyjna's Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes for Synektik Spólka Akcyjna is moderate due to the presence of alternative products and services in the market.

Bargaining Power Of Customers

The bargaining power of customers is high due to the availability of alternative products and services, and the ability of customers to switch to competitors.

Bargaining Power Of Suppliers

The bargaining power of suppliers is low due to the company's strong relationships with suppliers and the availability of alternative suppliers.

Threat Of New Entrants

The threat of new entrants is moderate due to the presence of barriers to entry, such as high capital requirements and regulatory hurdles.

Intensity Of Rivalry

The intensity of rivalry is high due to the presence of several competitors in the market, and the need to differentiate products and services to gain a competitive advantage.

9. SWOT Analysis

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 12.33%
Debt Cost 9.81%
Equity Weight 87.67%
Equity Cost 9.81%
WACC 9.81%
Leverage 14.06%

11. Quality Control: Synektik Spólka Akcyjna passed 8 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Synektik

A-Score: 5.9/10

Value: 1.8

Growth: 9.8

Quality: 7.5

Yield: 5.0

Momentum: 8.5

Volatility: 3.0

1-Year Total Return ->

Stock-Card
Drägerwerk

A-Score: 5.7/10

Value: 7.7

Growth: 3.3

Quality: 4.8

Yield: 3.8

Momentum: 9.5

Volatility: 5.3

1-Year Total Return ->

Stock-Card
EL.En

A-Score: 5.7/10

Value: 5.6

Growth: 6.1

Quality: 7.6

Yield: 6.2

Momentum: 5.0

Volatility: 3.7

1-Year Total Return ->

Stock-Card
ChemoMetec

A-Score: 4.8/10

Value: 0.0

Growth: 7.8

Quality: 9.4

Yield: 0.6

Momentum: 9.5

Volatility: 1.7

1-Year Total Return ->

Stock-Card
Eckert & Ziegler

A-Score: 4.7/10

Value: 2.0

Growth: 7.1

Quality: 7.5

Yield: 1.2

Momentum: 7.5

Volatility: 3.0

1-Year Total Return ->

Stock-Card
Guerbet

A-Score: 2.7/10

Value: 7.8

Growth: 2.6

Quality: 2.0

Yield: 2.5

Momentum: 0.0

Volatility: 1.3

1-Year Total Return ->

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

273.0$

Current Price

273$

Potential

-0.00%

Expected Cash-Flows